Full-Time
Updated on 9/3/2026
Handheld ultrasound device for point-of-care imaging
$185k/yr
No H1B Sponsorship
New York, NY, USA + 1 more
More locations: Burlington, MA, USA
Hybrid
At least two days per week in the office; travel up to 50% required.
Bachelor's
See people who can refer or advise you
Butterfly Network makes medical imaging tools, focusing on point-of-care ultrasound (POCUS). Its main product is the Butterfly iQ, a handheld ultrasound device that uses a single probe to scan the whole body. The iQ connects to a software platform, storing images, supporting telehealth, and providing advanced imaging tools. The device is sold to doctors, nurses, and medical technicians in hospitals, clinics, and rural settings, with revenue from device sales, software subscriptions, and educational resources. What sets Butterfly Network apart is its single-probe, portable design that aims to simplify ultrasound workflows and make high-quality imaging more affordable and accessible, especially in underserved areas. The company’s goal is to improve diagnostic access and patient outcomes worldwide by delivering cost-effective, easy-to-use ultrasound technology that integrates hardware and software in one connected system.
Company Size
201-500
Company Stage
IPO
Headquarters
Burlington, Massachusetts
Founded
2011
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health, dental & vision insurance
Equity
401k
PTO
Flexible hybrid work
Parental leave
Home office stipend
Rewards & recognition program
LinkedIn Learning
Merge Labs, a brain-interface startup backed by OpenAI and Sam Altman, has selected Butterfly Network as its exclusive ultrasound-on-chip supplier under a multiyear agreement. The deal includes upfront payments, development milestones, purchase commitments, access fees, and potential royalties, though specific amounts were not disclosed. Butterfly's semiconductor-based ultrasound architecture makes the system programmable and easier to embed in new devices. The company retained rights to license its technology to other partners. Butterfly's second-quarter revenue increased 39% to $32.6 million, with gross margin expanding to 71.4%. Adjusted EBITDA loss narrowed 78% to $1.4 million. Management raised full-year revenue guidance to $119 million to $123 million. Thirty-three hedge funds held Butterfly Network in the second quarter, up from 26 in the first quarter.
Central banks signalling fewer interest rate hikes could support early-stage AI companies outside big tech. A new screener has identified 29 AI small-cap stocks positioned to benefit from the next wave of machine learning and automation. Butterfly Network, a medical imaging company, combines handheld ultrasound devices with AI-powered Compass software. The firm recently posted record quarterly revenue with strong gross margins. However, it remains unprofitable and trades at a high price-to-sales multiple, whilst experiencing significant insider selling. Pagaya Technologies operates an AI-driven loan decisioning platform serving banks, fintechs, and auto lenders. The platform assesses and prices consumer and small business credit in real time. The screener surfaced 26 additional companies with similar growth potential in AI-powered sectors.
Joseph Devivo, president and CEO of Butterfly Network, sold 68,346 shares of Class A common stock on 10 August 2026, according to a SEC Form 4 filing. The transaction, valued at approximately $684,143, was executed through a Rule 10b5-1 trading plan adopted in December 2025. Following the sale, Devivo retains direct ownership of approximately 7.6 million shares, representing a market value of roughly $74 million. Butterfly Network shares closed at $9.37 on 11 August 2026, having achieved a 629% return over the preceding 12 months. The Burlington-based medical device company, which manufactures portable ultrasound imaging devices including the Butterfly iQ, reported trailing-twelve-month revenue of $112 million and a net loss of $75 million. The company maintains a market capitalisation of $2.3 billion.
Butterfly Network raised its full-year 2026 revenue guidance to $119 million–$123 million, driven by growth in Point-of-Care Ultrasound, Home and Community Care, and Embedded partnerships. The company reported record gross margins of 71%, attributed to high-margin contributions from its Embedded segment. The Embedded business saw revenue increase 439%, primarily from the Midjourney partnership. Butterfly's enterprise software pipeline, Compass AI, has grown fivefold since last year. The company now serves 80% of US medical schools. International revenue fell 14% due to timing of large deals shifting to Q3. The company expects its first Home and Community Care commercial implementation on 1 October, with Q4 revenue anticipated. Butterfly plans to launch a next-generation probe in Q1 2027 and enter the ultrasound cart market in late 2027 with iQ Station.
Jonathan Rothberg, founder and independent director of Butterfly Network, sold approximately 3.1 million Class B shares at $6.64 each, totalling $20.7 million, according to an SEC filing. The sale was conducted under a Rule 10b5-1 trading plan adopted in March 2026 for estate planning purposes. Following the transaction, Rothberg directly holds roughly 106,000 shares and indirectly controls about 19.6 million shares through various entities including family trusts. The sale occurred as Butterfly Network shares returned 263% over the preceding 12 months. Butterfly Network develops portable ultrasound imaging devices that connect to smartphones and tablets. The company has a market capitalisation of $1.8 billion, with trailing twelve-month revenue of $102.9 million and a net loss of $75.8 million.